Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
This company has no offices yet